Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$323,626
+$29,735 QoQ
Shares Held
2,065
+7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,086
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Forvis Mazars Wealth Advisors, LLC holds $83,206,945 across 10 Drug Manufacturers - General names. NVS ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
42,430 | $50,891,819 | |
| 2 | JNJ |
Johnson & Johnson
|
56,938 | $14,460,543 | |
| 3 | ABBV |
AbbVie Inc.
|
28,316 | $7,125,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,526 | $6,364,091 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
25,031 | $1,442,286 | |
| 6 | PFE |
Pfizer Inc
|
44,567 | $1,073,173 | |
| 7 | AMGN |
Amgen Inc
|
2,240 | $811,148 | |
| 8 | AZN |
Astrazeneca PLC
|
2,202 | $417,543 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $323,626 | 2,065 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $293,891 | 1,924 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $266,364 | 1,932 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $269,432 | 2,101 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $318,014 | 2,628 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $326,190 | 2,926 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $266,240 | 2,736 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $319,525 | 2,778 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $298,833 | 2,807 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $252,948 | 2,615 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $382,272 | 3,786 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $440,442 | 4,324 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $724,836 | 7,183 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $420,900 | 4,575 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $470,111 | 5,182 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $419,575 | 5,520 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $504,390 | 5,967 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $456,914 | 5,207 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $330,199 | 3,775 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $275,680 | 3,371 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $232,935 | 2,553 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $310,377 | 3,631 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $344,669 | 3,650 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $229,226 | 2,636 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $234,595 | 2,686 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $206,289 | 2,502 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||